Navigation Links
Latest Weapon in Battle against Drug-Resistant Bacteria

With the increase in drug resistant bacterial infections scientists have developed a new generation of antibiotics that stop the bacteria’s ability to spread infection//. With this approach bacteria has been rendered benign rather killed. This development shows promise towards in the battle against bacteria in the light of several antibiotics losing their potency against pathogens which have developed drug resistance.

Tests have shown that these compounds actively blocked the spread of Pseudomonas aeruginosa, which is a common bacterium that causes fatal lung infections in people with cystic fibrosis as well as leads to life-threatening blood infections in patients who have serious burns or immune system disorders such as Aids.

Researchers have found that colonies of bacteria use chemical signals to keep a check on their numbers and attack when their populations are large enough to ensure they can overcome a host's immune defenses. When the chemical signals received by the bacteria reach a certain threshold behavior changes dramatically, become aggressive, turning on virulence genes to cause infection. Besides that several bacterial colonies also set up defenses by the secretion of mucus-like substance that forms a slimy, protective "biofilm" around them, which makes them nearly impervious to antibiotics.

In 2002 the US National Institute of Health estimated that over 80% of bacterial infections spread by using biofilms which offer such good protection that very often the bacteria could be killed only by giving the patient a lethal dose of antibiotics.

Researchers at the University of Wisconsin-Madison used microwave-assisted chemistry for designing compounds called N-acylated L-homoserine lactones (AHLs) which although similar to those used by bacteria, differ in that when they come into contact with bacteria they make the bacteria oblivious to their neighbours. As a result, their communication system is cut and the bacteria
'"/>




Page: 1 2

Related medicine news :

1. Latest device for identifying Melanomas
2. Latest discovery on Autism
3. Latest device for cardiac revival under test
4. Latest technique for asthma treatment
5. Latest drug shows promise in multiple myeloma
6. Latest Findings On The Deadly Disease - SARS
7. Latest Tumor Classification More Informative
8. The Latest Preventative Treatment Option for Prostate Cancer
9. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
10. A Latest Study Links Fish To Stroke
11. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
Post Your Comments:
Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 1Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 2Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 3Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 4Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 5StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 1StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 2StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 3StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 4National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 1National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 2National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 3National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 4